Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.72B 4.29B 547M 479M 441M 409M 776M 51.92B 789M 5.29B 2.06B 25.62B 2.05B 2.01B 88.57B P/E 2026 *
8.18x
P/E 2027 * 7.26x
Enterprise Value 3.72B 4.29B 547M 479M 441M 409M 776M 51.92B 789M 5.29B 2.06B 25.62B 2.05B 2.01B 88.57B EV / Sales 2026 *
0.53x
EV / Sales 2027 * 0.49x
Free-Float
45.7%
Yield 2026 *
5.51%
Yield 2027 * 6.2%
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
11-28 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective November 28, 2025 CI
1 day-0.59%
1 week+3.72%
Current month+4.69%
1 month-5.90%
3 months-15.62%
6 months-26.05%
Current year-24.04%
1 week 3.21
Extreme 3.21
3.43
1 month 3.07
Extreme 3.07
3.67
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.52
3 years 3.07
Extreme 3.07
7.41
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 03/06/2025
Compliance Officer 47 27/11/2025
Comptroller/Controller/Auditor 48 03/06/2025
Director TitleAgeSince
Director/Board Member 67 09/02/2011
Director/Board Member 69 11/06/2018
Director/Board Member 82 11/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%+3.72%-31.91%-51.09% 550M
-1.28%+0.25%-12.80%-6.12% 12.94B
-2.61%-1.95%-35.36%-56.79% 4.79B
-1.30%+2.45%-8.29%-3.97% 4.49B
-1.40%+4.11%+21.86%-2.64% 3.92B
-3.16%-1.54%+2.00%-39.12% 3.89B
-2.77%+2.56%-11.93%+3.47% 3.17B
-0.99%-12.50%-11.33%-15.42% 3.16B
-2.57%-0.39%-8.84%-24.74% 2.41B
+0.66%+7.73%-8.80%+40.75% 1.77B
Average -1.60%+2.37%-10.54%-15.57% 4.11B
Weighted average by Cap. -1.70%+1.71%-9.90%-14.23%

Financials

2026 *2027 *
Net sales 6.98B 8.06B 1.03B 899M 829M 768M 1.46B 97.52B 1.48B 9.94B 3.86B 48.13B 3.86B 3.77B 166B 7.56B 8.73B 1.11B 974M 898M 832M 1.58B 106B 1.6B 10.76B 4.19B 52.13B 4.18B 4.09B 180B
Net income 454M 525M 66.89M 58.53M 53.94M 50M 94.92M 6.35B 96.44M 647M 252M 3.13B 251M 246M 10.83B 514M 593M 75.57M 66.13M 60.95M 56.49M 107M 7.17B 109M 731M 284M 3.54B 284M 278M 12.23B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
07/07/26 HK$3.350 -0.59% 592,000
06/07/26 HK$3.370 +0.90% 767,000
03/07/26 HK$3.340 +3.41% 588,000
02/07/26 HK$3.230 +0.94% 1,350,000
30/06/26 HK$3.200 -0.93% 537,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.902CNY
Average target price
4.601CNY
Spread / Average Target
+58.53%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock